Cummings Keith Lamont bought PLRX
January 22, 2026 · Form 4 insider transaction
Cummings Keith Lamont bought 400,000 shares of Pliant Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
400,000
Price
$0.00
Total value
N/A
InsiderCummings Keith Lamont
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 22, 2026
Filing dateJanuary 26, 2026
Shares owned after400,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.